Susquehanna International Group, LLP Pulse Biosciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$6.69 - $14.54 $602,769 - $1.31 Million	-90,100 Reduced 41.22%	128,500 $1.44 Million
Q1 2024 May 07, 2024	BUY	$7.8 - $11.02 $7,020 - $9,918	900 Added 0.41%	218,600 $1.9 Million
Q4 2023 Feb 14, 2024	BUY	$3.85 - $12.84 $206,360 - $688,224	53,600 Added 32.66%	217,700 $2.66 Million
Q3 2023 Nov 14, 2023	BUY	$4.03 - $8.73 $579,111 - $1.25 Million	143,700 Added 704.41%	164,100 $661,000
Q2 2023 Aug 11, 2023	SELL	$3.67 - $8.64 $602,981 - $1.42 Million	-164,300 Reduced 88.96%	20,400 $146,000
Q1 2023 May 16, 2023	SELL	$2.48 - $3.88 $327,112 - $511,772	-131,900 Reduced 41.66%	184,700 $620,000
Q4 2022 Feb 14, 2023	SELL	$1.73 - $2.89 $172,481 - $288,133	-99,700 Reduced 23.95%	316,600 $876,000
Q3 2022 Nov 14, 2022	BUY	$1.23 - $2.3 $512,049 - $957,489	416,300 New	416,300 $957,000
Q4 2021 Feb 14, 2022	SELL	$14.78 - $24.4 $1.43 Million - $2.36 Million	-96,800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.25 - $26.63 $1.23 Million - $1.9 Million	71,500 Added 282.61%	96,800 $2.09 Million
Q4 2020 Feb 16, 2021	BUY	$11.66 - $24.5 $294,998 - $619,850	25,300 New	25,300 $604,000
Q3 2020 Nov 16, 2020	SELL	$9.27 - $13.14 $342,063 - $484,866	-36,900 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.23 - $13.09 $38,626 - $81,158	6,200 Added 20.2%	36,900 $386,000
Q1 2020 May 15, 2020	BUY	$5.23 - $15.2 $55,961 - $162,640	10,700 Added 53.5%	30,700 $220,000
Q4 2019 Feb 14, 2020	SELL	$12.58 - $15.97 $6,290 - $7,985	-500 Reduced 2.44%	20,000 $268,000
Q3 2019 Nov 14, 2019	SELL	$10.73 - $17.33 $887,371 - $1.43 Million	-82,700 Reduced 80.14%	20,500 $317,000
Q2 2019 Aug 14, 2019	BUY	$11.11 - $17.34 $116,655 - $182,070	10,500 Added 11.33%	103,200 $1.36 Million
Q1 2019 May 15, 2019	BUY	$11.69 - $19.44 $1.08 Million - $1.8 Million	92,700 New	92,700 $1.63 Million
Q3 2018 Nov 14, 2018	SELL	$12.83 - $16.45 $288,675 - $370,125	-22,500 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$14.04 - $20.28 $74,412 - $107,484	-5,300 Reduced 19.06%	22,500 $341,000
Q1 2018 May 15, 2018	BUY	$12.67 - $24.69 $10,136 - $19,752	800 Added 2.96%	27,800 $376,000
Q4 2017 Feb 14, 2018	SELL	$18.81 - $30.33 $336,699 - $542,907	-17,900 Reduced 39.87%	27,000 $637,000
Q3 2017 Nov 14, 2017	BUY	$10.26 - $24.97 $460,674 - $1.12 Million	44,900	44,900 $836,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

4.8M

Call Options Held

138K

Put Options Held

96.2K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $541M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account